Guillain-Barré Syndrome after COVID-19 Vaccine: Should We Assume a Causal Link?
Santvana Kohli, Mudit Varshney, Sandeep Mangla, Binita Jaiswal, Priyanka H. Chhabra
International Journal of Medical and Pharmaceutical Case Reports · pp. 20–24 · Published 29 May 2021
10.9734/ijmpcr/2021/v14i130124Abstract
The virus SARS-CoV2 and the disease spectrum caused by it have led to a widespread impact on the medical and economic status of all nations of the world. This led to an expedited mission to introduce a vaccine which could attempt to neutralize the pandemic to some extent. Many vaccines have been introduced with an acceptable safety profile, producing only mild adverse effects of soreness at injection site, malaise, fever, diarrhoea, myalgia and uncommonly allergic/anaphylactic reactions and possibility of getting infected with SARS-CoV2. Some isolated reports have also emerged of serious thromboembolic phenomena and neurological complications such as Guillain-Barré Syndrome (GBS). A similar incident was noticed at our institute, where a 71 year old male recipient of COVID-19 vaccine at an immunization centre, presented to us with features of GBS. We hereby report this case, not establishing a direct link between the two, but to raise awareness regarding the ongoing mass immunization world-wide.
References (17)
- 1 Extrapulmonary manifestations of COVID-19 [DOI]
- 2 Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome [DOI]
- 3 COVID‐19–associated Guillain‐Barré syndrome: The early pandemic experience [DOI]
- 4 Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine [DOI]
- 5 Guillain-Barre Syndrome, Influenza, and Influenza Vaccination: The Epidemiologic Evidence [DOI]
- 6 Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions [DOI]
- 7 Guillain–Barré syndrome, transverse myelitis and infectious diseases [DOI]
- 8 Guillain-Barré syndrome and influenza vaccines: A meta-analysis [DOI]
- 9 Vaccine-preventable diseases, vaccines and Guillain-Barre’ syndrome [DOI]
- 10 Guillain–Barré syndrome after SARS‐CoV‐2 infection [DOI]
- 11 Reflections on the 1976 Swine Flu Vaccination Program [DOI]
- 12 Does Campylobacter jejuni infection elicit “demyelinating” Guillain–Barre syndrome? [DOI]
- 13 Cumulative Risk of Guillain–Barré Syndrome Among Vaccinated and Unvaccinated Populations During the 2009 H1N1 Influenza Pandemic [DOI]
- 14 Pathophysiological Mechanisms and Neurological Manifestations in COVID-19 [DOI]
- 15 Serial single breath count is a reliable tool for monitoring respiratory functions in Guillain-Barré Syndrome [DOI]
- 16 Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany [DOI]
- 17 Neurological Manifestations of COVID-19: A Series of Seven Cases [DOI]
Cited by 10
Aparajita Chatterjee, Ambar Chakravarty · Current Neurology and Neuroscience Reports · 2022
Roya Hosseini, Nayere Askari · European Journal of Medical Research · 2023
Ravindra Kumar Garg, Vimal Kumar Paliwal · Neurological Sciences · 2021
Sayed S. Sayed, Mohamed El-Sayed El-Khatib, Mohamed Abdelghaffar · The Egyptian Journal of Neurology, Psychiatry and Neurosurgery · 2024
RavindraKumar Garg, Vimal Paliwal, HardeepSingh Malhotra · Neurology India · 2023
Showing 5 of 10 known citations — external sources report more than can currently be individually listed.
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
58
Page views
0
PDF downloads
21
Outbound clicks
10
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.